{"version":"1.2.0","chapters":[{"startTime":0,"endTime":38.238},{"startTime":38.238,"endTime":75.255,"title":"Introduction to Associate Professor Yette Kaur"},{"startTime":75.255,"endTime":120.33,"title":"Understanding Interstitial Pneumonia Classification"},{"startTime":120.33,"endTime":362.052,"title":"Evolution of IIP Statements Over Two Decades"},{"startTime":362.052,"endTime":606.42,"title":"Changes in the 2013 IIP Statement"},{"startTime":606.42,"endTime":870.324,"title":"Advancements Since 2013: New Guidelines"},{"startTime":870.324,"endTime":1140.17,"title":"Linking Idiopathic and Secondary Causes"},{"startTime":1140.17,"endTime":1355.005,"title":"Antigen-Negative Fibrotic HP: A Unique Group?"},{"startTime":1355.005,"endTime":1625.847,"title":"Looking Ahead: Future Directions in Research"}]}